Home

Par Drugs & Chemicals Ltd PE Ratio

Image

Par Drugs & Chemicals Ltd

NSE: PAR

PE

12.8

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Par Drugs & Chemicals Ltd is 12.8 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Par Drugs & Chemicals Ltd changed from 4.1 on March 2020 to 18.3 on March 2024 . This represents a CAGR of 34.88% over 5 years.
  • The Latest Trading Price of Par Drugs & Chemicals Ltd is ₹ 187.57 as of 15 Jan 15:56 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Par Drugs & Chemicals Ltd

No data available

Company Fundamentals for Par Drugs & Chemicals Ltd

Image

Par Drugs & Chemicals Ltd

NSE: PAR

Share Price

₹ 187.57

-2.67 (-1.40%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Par Drugs & Chemicals Ltd

1M

1Y

3Y

5Y

Monitoring Par Drugs & Chemicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025190.24
13 Jan 2025182.7
10 Jan 2025198.52
09 Jan 2025204.4
08 Jan 2025203.75
07 Jan 2025206.03
06 Jan 2025202.09
03 Jan 2025213.77
02 Jan 2025217.99
01 Jan 2025207.22

SWOT Analysis Of Par Drugs & Chemicals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Par Drugs & Chemicals Ltd

Asset Value vs Market Value of Par Drugs & Chemicals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Par Drugs & Chemicals Ltd234.08
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Par Drugs & Chemicals Ltd Explained

``

234.08

Market cap

18

Earnings

12.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Par Drugs & Chemicals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Par Drugs & Chemicals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Par Drugs & Chemicals Ltd

No data available

* All values are in %

About Par Drugs & Chemicals Ltd

  • Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat.
  • On 26 February 1999.
  • Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.
  • APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat.

Par Drugs & Chemicals Ltd News Hub

Par Drugs & Chemicals AGM scheduled

Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he

Read more

2024-08-19 00:00:00

Par Drugs & Chemicals to declare Quarterly Result

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024

Read more

2024-08-10 00:00:00

Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter

Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag

Read more

2024-08-05 00:00:00

Par Drugs & Chemicals to declare Quarterly Result

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202

Read more

2024-10-14 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Par Drugs & Chemicals Ltd

What is the current PE Ratio of Par Drugs & Chemicals Ltd?

The Current PE Ratio of Par Drugs & Chemicals Ltd is 12.81 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Par Drugs & Chemicals Ltd last year?

The PE Ratio of Par Drugs & Chemicals Ltd was 15.2 last year, now the PE ratio is 12.81, showing a year-on-year growth of -15.7%.

What does the PE Ratio of Par Drugs & Chemicals Ltd indicate about its stock?

The PE Ratio of Par Drugs & Chemicals Ltd is 12.81. This ratio indicates that investors are willing to pay 12.81 times the earnings per share for each share of Par Drugs & Chemicals Ltd.

What is the PE Ratio Growth of Par Drugs & Chemicals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Par Drugs & Chemicals Ltd grew by -15.7% whereas, the EPS ratio grew by 239.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions